Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04799 |
| Species: | Homo sapiens |
| Position : | chr1:230294600-230294900 |
| Year: | 2016 |
| Title: | Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26817450 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Hep-G2 |
| CVCL ID: | CVCL_0027 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | GWAS-linked HDL-C regulatory variant; allele-specific enhancer activity and TF binding |
| High Throughput Method: | GWAS; ENCODE/ChIP-seq regulatory-data integration |
| Low Throughput Method: | Dual-luciferase/allele-specific reporter; EMSA; ChIP/ChIP-qPCR; RT-qPCR |
| Target gene : | GALNT2 |
| TF name : | ZBTB3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04808 | chr1:230293530-230305966 | liver | hepatocyte | NA |
| E_04796 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04797 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04798 | chr1:230294600-230294900 | liver | malignant cell | NA |
| E_04807 | chr1:230294600-230294900 | liver | malignant cell | NA |